Cognition Therapeutics Inc. Skyrocketed

Mon, Jan 31, 2022 at 05:30 PM

Cognition Therapeutics Inc. (CGTX:NASDAQ) soared at $4.4, a gain of 26.8%. On Fri, Jan 28, 2022, CGTX:NASDAQ touched a New 2-Week Low of $3.47. The stock got featured on our News Catalysts scanner on Mon, Jan 10, 2022 at 09:14 AM in the 'INVESTOR UPDATE' category. From Tue, Jan 18, 2022, the stock recorded 37.50% Up Days and 33.33% Green Days

About Cognition Therapeutics Inc. (CGTX:NASDAQ)

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative...

Top 10 Gainers:

Calithera Biosciences, Inc. (CALA:NASDAQ), 55.65%
Inspira Technologies Oxy B.H.N. Ltd. (IINN:NASDAQ), 36.52%
Vaccinex, Inc. (VCNX:NASDAQ), 33.63%
Bassett Furniture Industries, Incorporated (BSET:NASDAQ), 33.14%
Knightscope Inc. (KSCP:NASDAQ), 31.37%
FGI Industries Ltd. (FGI:NASDAQ), 28.91%
Provention Bio, Inc. (PRVB:NASDAQ), 28.85%
Astria Therapeutics Inc. (ATXS:NASDAQ), 27.48%
Cognition Therapeutics Inc. (CGTX:NASDAQ), 26.8%
Romeo Power Inc. Class A (RMO:NYSE), 25.53%